Clinical Trial Update: Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

View source ↗

Summary

This document reports real-world experience with upadacitinib for moderate-to-severe adult atopic dermatitis in a completed study (ERUDA). It summarizes observa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse | Conditions: Atopic Dermatitis | Status: COMPLETED